To page body
university of tampere:
BioMediTechTampereen yliopisto BioMediTech

BioMediTech joint Institute Website


BMT seminar serie 2016

Program
Thursdays in Arvo Auditoriums
Please note the varying times and days

BMT Journal Clubs 2016

List of the clubs
All interested are welcome to attend these meetings

Services






BioMediTech

BioMediTech at the University of Tampere (UTA) is part of the joint BioMediTech institute of the UTA and Tampere University of Technology (TUT).

BioMediTech is a joint institute of the University of Tampere (UTA) and Tampere University of Technology (TUT). Its research activities cover diverse areas, including cell and molecular biology, genetics, biomaterials, biosensors, computational systems, biotechnology, biomedical engineering, and regenerative medicine.

At BioMediTech, UTA and TUT educate together top-level experts with multidisciplinary skills in life sciences for the demands of both academia and industry. The students apply to and their studies are administered by either UTA or TUT.

These pages concentrate on the BioMediTech activities administered by the University of Tampere. The issues concerning the joint institute can be found on the institute's webpages.

In the Spotlight

ristola-yla-outinen-100816-JR-01-_230.jpg

Researchers at BioMediTech at the University of Tampere are investigating spinal cord injuries (SCI) in ways that could definitively improve the quality of life of SCI patients. Postdoctoral Researcher Laura Ylä Outinen (left) is working on a three-year Academy of Finland-funded project to develop a three dimensional stem cell model, which will be used to investigate the function of the spinal cord. The main goal is to develop a model utilising the technological development of cell transplants in the treatment of SCI patients.

Postdoctoral Researcher Mervi Ristola (right) studies stem cells as tools to develop a myelination model. The aim is to use the model to study the formation of the myelin sheath around neurons and to determine what happens when the myelin is damaged. This will enable researchers to gain a better understanding of the mechanisms of the demyelinating diseases and develop new therapies for them.

Read more on UTA Research News

Follow us in Facebook Facebook Follow us in Twitter Twitter

 

eu_aluekehitysrahasto.jpg http://www.uta.fi/uusi-ibt/tiedostot/vipuvoimaa_EUlta.jpg
 
BioMediTech
Lääkärinkatu 1
33520 Tampere, Finland
Maintained by: webmaster@biomeditech.fi
Last update: 19.9.2016 8.50 Muokkaa

University of Tampere
+358 3 355 111
registry@uta.fi


FINEEC Audited HR Excellence in Research

THE UNIVERSITY
Research
Admissions
Studies
News
Cooperation and Services
About Us

CURRENT ISSUES
Research & Study
Tampere3
Vacancies

SERVICES
Administration
Career Services
Finnish Social Science Data Archive
Centre for International Education
IT services
Language Centre
Language Services
Library
Registrar's Office
Registry
Sports Activities
» more

STUDIES
Teaching schedules
Curricula guides
Student's Desktop

ONLINE SERVICES
UTA intranet
Office 365 webmail
Uta webmail
Moodle
NettiOpsu
NettiKatti
Nelli
TamPub
Tamcat
Electronic exam service
Examination results